Search Results - "NOIZE, P."

Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case–case–control study by Coppry, M, Jeanne-Leroyer, C, Noize, P, Dumartin, C, Boyer, A, Bertrand, X, Dubois, V, Rogues, A -M

“…Abstract Background Carbapenem-resistant Pseudomonas aeruginosa (CRPA) strains are involved in severe infections, mostly in ICUs. Exposure to antibiotics other…”
Get full text

Patterns of selective serotonin reuptake inhibitor use and risk of falls and fractures in community-dwelling elderly people: the Three-City cohort by Carrière, I., Farré, A., Norton, J., Wyart, M., Tzourio, C., Noize, P., Pérès, K., Fourrier-Réglat, A., Ancelin, M. L.

“…Summary In this population-based elderly cohort, participants using selective serotonin reuptake inhibitor (SSRI) antidepressants have an increased risk of…”
Get full text

Agreement between hospital discharge diagnosis codes and medical records to identify metastatic colorectal cancer and associated comorbidities in elderly patients by Gouverneur, A, Dolatkhani, D, Rouyer, M, Grelaud, A, Francis, F, Gilleron, V, Fourrier-Réglat, A, Noize, P

“…Quality of coding to identify cancers and comorbidities through the French hospital diagnosis database (Programme de médicalisation des systèmes d'information,…”
Get more information

O-074: Antidepressant use and cognitive decline in elderly people by Carriere, I, Farre, A, Norton, J, Wyart, M, Noize, P, Peres, K, Fourrier-Reglat, A, Ancelin, M.L

Get full text

Valvular heart disease in a patient taking benfluorex by Noize, P., Sauer, M., Bruneval, P., Moreau, M., Pathak, A., Bagheri, H., Montastruc, J.L.

“…The authors describe a case of valvular heart disease in a 48‐year‐old woman receiving benfluorex (150 mg t.i.d. for 8 years) and leading to surgical mitral…”
Get full text

NSAIDs discontinuation and myocardial infarction by SALVO, F., PARIENTE, A., NOIZE, P., FOURRIER‐RÉGLAT, A., MOORE, N.

Get full text

Real-Life Use of Cetuximab in 1st-Line Treatment of Unresectable Metastatic Colorectal Cancer (MCRC) and Outcomes After Surgical Resection of Metastases: Updated Data from the Erebus Cohort by Smith, D., Sa-cunha, A., Rouyer, M., François, E., Mitry, E., Monnereau, A., Jové, J., Bignon, E., Balestra, A., Noize, P., Moore, N., Fourrier-Reglat, A.

Get full text

Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (MCRC): Patient Characteristics, Safety and Effectiveness in the Erebus Cohort by Smith, D., Rouyer, M., Mitry, E., Francois, E., Monnereau, A., Sa-Cunha, A., Jove, J., Noize, P., Moore, N., Fourrier-Réglat, A.

Get full text

649 - Use of Cetuximab (CTX) in 1st-Line Therapy of Metastatic Colorectal Cancer (MCRC): Patient Characteristics, Safety and Effectiveness in the Erebus Cohort by Smith, D., Rouyer, M., Mitry, E., Francois, E., Monnereau, A., Sa-Cunha, A., Jove, J., Noize, P., Moore, N., Fourrier-Réglat, A.

“…CTX has demonstrated improved survival outcomes in mCRC but information in real-life is sparse. EREBUS is a French multicentre cohort with 92 centres. Patients…”
Get full text

Cetuximab in first-line treatment of metastatic colorectal cancer in a real-life setting: Preliminary results of the EREBUS cohort by Smith, Denis, Rouyer, Magali, Mitry, Emmanuel, Monnereau, Alain, Sa Cunha, Antonio, Bignon, Emmanuelle, Le Monies, Alise, Jove, Jeremy, Noize, P., Moore, Nicholas, Fourrier-Réglat, Annie

“…Abstract only 621 Background: Cetuximab (CTX) has demonstrated to improve survival outcomes in metastatic colorectal cancer (mCRC), but little data for…”
Get full text

Effectiveness and safety in very elderly patients treated by bevacizumab (BV) plus chemotherapy in first-line therapy of metastatic colorectal cancer: Results of ETNA, a French cohort study by Smith, D., Rouyer, M., Noize, P., Lassalle, R., Bernard, O., Burki, F., Guichard, P., Ravaud, A., Moore, N., Fourrier-Ráglat, A.

“…Abstract only 555 Background: In view of the ageing population, oncogeriatrics has become a priority for public health. Elderly cancer patients are often…”
Get full text

Cutaneous Adverse Effects of Ketoprofen for Topical Use: Clinical Patterns and Costs by Noize, Pernelle, Bénard-Laribière, Anne, Aulois-Griot, Marine, Moore, Nicholas, Miremont-Salamé, Ghada, Haramburu, Françoise

“…Background : Since its introduction in France, ketoprofen for topical use has been associated with a large number of cutaneous adverse effect reports…”
Get full text

CASE REPORT: Valvular heart disease in a patient taking benfluorex by Noize, P, Sauer, M, Bruneval, P, Moreau, M, Pathak, A, Bagheri, H, Montastruc, J L

“…The authors describe a case of valvular heart disease in a 48-year-old woman receiving benfluorex (150 mg t.i.d. for 8 years) and leading to surgical mitral…”
Get full text

Déterminants de la survenue des effets indésirables médicamenteux : une étude cas-témoins réalisée à l’admission en milieu hospitalier by Dabadie, S., Noize, P., Vandenhende, M.-A., Bernard, N., Miremont-Salamé, G., Lacoste, D., Pometan, J.-P., Morlat, P., Bonnet, F.

Get full text

R131 Chirurgie des métastases après traitement en première ligne du cancer colorectal par bévacizumab : résultats de la cohorte ETNA by Smith, D., Ravaud, A., Rouyer, M., Guimbaud, R., Balestra, A., Becouarn, Y., Lassalle, R., Terrebonne, E., Noize, P., Grelaud, A., Moore, N., Fourrier-Réglat, A.

Get full text

R132 – Oral Efficacité et modalités d’utilisation du bortézomib en situation réelle de soins : résultats de la cohorte VESUVE by Fourrier-Réglat, A., Grelaud, A., Burtin, C., Eghbali, H., Fitoussi, O., Marit, G., Monnereau, A., Noize, P., Bignon, E., Lassalle, R., Jove, J., Moore, N.

Get full text

Valvular heart disease in a patient taking benfluorex by Noize, P., Sauer, M., Bruneval, P., Moreau, M., Pathak, A., Bagheri, H., Montastruc, J.L.

Get full text